Lumos Diagnostics (ASX:LDX) Secures Additional Medicare Coverage
Lumos Diagnostics (ASX:LDX) expands Medicare reimbursement for FebriDx to over 55% of US coverage, enhancing market access.
Category: ASX-LDX
Lumos Diagnostics
Latest News
Lumos Diagnostics (ASX:LDX) Secures Additional Medicare Coverage
Hydrocarbon Dynamics Limited (ASX:HCD) Releases March 2025 Quarterly Report
Global Masters Fund Limited (ASX:GFL) Releases Quarterly Convertible Notes Report
Insignia Financial Ltd (ASX:IFL) Announces Q3 2025 Business Update
Cettire Limited (ASX:CTT) Announces Q3 FY25 Trading Update
Paladin Energy Ltd (ASX:PDN) Announces Quarterly Cash Flow Report
Telix Pharmaceuticals Limited (ASX:TLX) Reports $186M Q1 Revenue
Australasian Metals Limited (ASX:A8G) Announces Portfolio Rationalisation and Exploration Progress
Tower (ASX:TWR) Updates FY25 Guidance
ikeGPS Group Limited (ASX:IKE) Announces 4Q25 Performance Update
The Hub of Australian Finance News